Use of angiopoietin-2 serum levels as a clinical surrogate for vascular normalization under bevacizumab treatment

Valentin Goede,J. Neuneier,G. Kayoko,Martin R. Weihrauch,Oliver Coutelle,Roland Schnell,Thomas C. Koslowsky,Clemens-Martin Wendtner,Ulrich Hacker

Use of angiopoietin-2 serum levels as a clinical surrogate for vascular normalization under bevacizumab treatment

2008

Valentin Goede
J. Neuneier
G. Kayoko
Martin R. Weihrauch
Oliver Coutelle
Roland Schnell
Thomas C. Koslowsky
Clemens-Martin Wendtner
Ulrich Hacker

4133 Background: The combination of chemotherapy and the anti-VEGF antibody bevacizumab (BV) is the current standard treatment for advanced colorectal cancer (CRC). Previous efforts to identify bio...

Keywords:

Oncology
Bevacizumab
Pathology
Angiopoietin 2
Normalization (statistics)
Medicine
Internal medicine
Diabetes mellitus
Standard treatment
Chemotherapy
advanced colorectal cancer
vascular normalization
Antibody

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations